<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id>
<journal-title>Frontiers in Physiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Physiol.</abbrev-journal-title>
<issn pub-type="epub">1664-042X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1620785</article-id>
<article-id pub-id-type="doi">10.3389/fphys.2025.1620785</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Physiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Cardiopulmonary and hemodynamic responses to <italic>Baduanjin</italic> exercise and cycle ergometer exercise among chronic heart failure patients: a comparison</article-title>
<alt-title alt-title-type="left-running-head">Chen et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphys.2025.1620785">10.3389/fphys.2025.1620785</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Chen</surname>
<given-names>Xiankun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1338112/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Hu</surname>
<given-names>Xiaoyue</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2610226/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Olson</surname>
<given-names>Thomas P.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1214210/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qiu</surname>
<given-names>Yaqi</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3195711/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Huiying</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2825529/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wen</surname>
<given-names>Zehuai</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/960306/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cai</surname>
<given-names>Huayang</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3195671/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Lu</surname>
<given-names>Weihui</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1936274/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Jiang</surname>
<given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1396224/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Clinical Research Center, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>The Second Clinical Medical College, Guangzhou University of Chinese Medicine</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Division of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic and Foundation</institution>, <addr-line>Rochester</addr-line>, <addr-line>MN</addr-line>, <country>United States</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Cardiology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Scientific Research, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1560247/overview">Guoxin Ni</ext-link>, First Affiliated Hospital of Xiamen University, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1439402/overview">Georgios A. Christou</ext-link>, University of Ioannina, Greece</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3137887/overview">Qian Luo</ext-link>, Sichuan University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Weihui Lu, <email>weihui.lu@gzucm.edu.cn</email>; Wei Jiang, <email>drjiangwei@126.com</email>
</corresp>
<fn fn-type="equal" id="fn001">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>09</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1620785</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>04</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>08</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Chen, Hu, Olson, Qiu, Zhu, Wen, Cai, Lu and Jiang.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Chen, Hu, Olson, Qiu, Zhu, Wen, Cai, Lu and Jiang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Objective</title>
<p>
<italic>Baduanjin</italic> is a traditional Chinese exercise and serves as an alternative to conventional cardiac rehabilitation in China. In this study, we compare the cardiopulmonary and hemodynamic responses of <italic>Baduanjin</italic> to those of cycle ergometer exercise in chronic heart failure patients.</p>
</sec>
<sec>
<title>Methods</title>
<p>For this cross-sectional study design, following baseline data collection, participants underwent a series of tests including impedance cardiography (ICG) and a maximal cardiopulmonary exercise test (CPET) to determine peak exercise capacity. Participants then engaged in 9-min of <italic>Baduanjin</italic> exercise. The average oxygen consumption (EqualVO<sub>2</sub>) during <italic>Baduanjin</italic> was calculated. Participants then engaged 9 min of constant-load cycling at 60 rpm at an intensity which elicited the EqualVO<sub>2</sub>. Cardiopulmonary and hemodynamic data were measured continuously during both Baduanjin and cycling exercise.</p>
</sec>
<sec>
<title>Results</title>
<p>A total of 30 participants were included. Although <italic>Baduanjin</italic> and cycling exercise showed similar VO<sub>2</sub> levels (8.2 &#xb1; 1.3 vs. 8.4 &#xb1; 1.4, <italic>p</italic> &#x3d; 0.339, respectively), there was a bimodal distribution during <italic>Baduanjin</italic> exercise compared to a unimodal distribution during cycling exercise. Compared to conventional cycling, <italic>Baduanjin</italic> demonstrated lower respiratory burden which is associated with greater ventilatory efficiency as evidenced by lower respiratory rate values (<italic>p</italic> &#x3d; 0.003), minute ventilation (<italic>p</italic> &#x3c; 0.001), end-tidal carbon dioxide pressure (<italic>p</italic> &#x3c; 0.001), and minute ventilation to carbon dioxide production ratio (<italic>p</italic> &#x3c; 0.001). In terms of hemodynamic response, <italic>Baduanjin</italic> is demonstrated significantly lower cardiac output (<italic>p</italic> &#x3d; 0.017) and elevated arterial-venous oxygen difference (<italic>p</italic> &#x3d; 0.036).</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Our study offers novel insight into the cardiopulmonary and hemodynamic differences between <italic>Baduanjin</italic> and cycling when performed at consistent intensity levels. <italic>Baduanjin</italic> demonstrates an intermittent intensity pattern and increased peripheral oxygen utilization, which is attributed to more pronounced muscle activation. Furthermore, <italic>Baduanjin</italic> has been linked to a reduction in both cardiac and respiratory burdens.</p>
</sec>
</abstract>
<kwd-group>
<kwd>chronic heart failure</kwd>
<kwd>
<italic>Baduanjin</italic>
</kwd>
<kwd>cycle ergometer exercise</kwd>
<kwd>cardiopulmonary response</kwd>
<kwd>hemodynamic response</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Exercise Physiology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Comprehensive exercise-based cardiac rehabilitation (CR) is a Class 1A recommend therapy for patients with chronic heart failure (HF) (<xref ref-type="bibr" rid="B22">Pelliccia et al., 2020</xref>; <xref ref-type="bibr" rid="B17">McDonagh et al., 2023</xref>; <xref ref-type="bibr" rid="B23">Ponikowski et al., 2016</xref>). Patients with HF who engage in exercise based CR demonstrate improved quality of life, reduced hospitalization, and lower mortality rates (<xref ref-type="bibr" rid="B19">Molloy et al., 2024-03</xref>; <xref ref-type="bibr" rid="B3">Bozkurt et al., 2021</xref>). However, these CR programs are underutilized, with participation rates ranging from 10% to 30% worldwide (<xref ref-type="bibr" rid="B2">Beatty et al., 2023</xref>; <xref ref-type="bibr" rid="B21">Ozemek and Squires, 2021</xref>; <xref ref-type="bibr" rid="B1">Balady et al., 2011</xref>; <xref ref-type="bibr" rid="B14">Grace et al., 2008-10</xref>; <xref ref-type="bibr" rid="B24">Sanderson et al., 2003</xref>). In China, primary barriers to participation in CR have been identified and include resource scarcity and limited healthcare funding (<xref ref-type="bibr" rid="B32">Zhang et al., 2023</xref>; Zhang et al.). Therefore, solutions to improving CR uptake HF patients must be tailored to these barriers. In addition to overcoming the above noted barriers, resource-adapted CR programs must be sensitive to the cultural context in which they are embedded.</p>
<p>Commonly accepted as beneficial to one&#x2019;s health, traditional Chinese exercise is a form of exercise embedded within communities throughout different regions of mainland China for nearly sixteen centuries (<xref ref-type="bibr" rid="B29">Wang et al., 2016</xref>; <xref ref-type="bibr" rid="B15">Health Qigong Management Center, 2003</xref>). Thus, this equipment-free exercise may be ideal for hospitals with limited resources (<xref ref-type="bibr" rid="B25">Sun, 2015</xref>), as well as patients, because it can be practiced at home, reducing barriers such as weather, transportation, and cost (<xref ref-type="bibr" rid="B10">Deka et al., 2017</xref>; <xref ref-type="bibr" rid="B7">Conraads et al., 2012</xref>). <italic>Baduanjin</italic>, translated as &#x201c;eight silken movements&#x201d;, is one form of traditional Chinese exercise which has been practiced for over 1,000 years. It is characterized by slow movements (physical training) synchronized with meditation (mindfulness-based training) and regulated breathing (respiratory training) to achieve a harmonious flow of energy (<italic>qi</italic>) in the body (<xref ref-type="bibr" rid="B33">Zou et al., 2017</xref>). <italic>Baduanjin</italic> is easy to learn, with minimal physical or cognitive demands, as it only entails eight simple movements based on traditional Chinese medicine theory. Moreover, it is an adaptable form of exercise that can be practiced in any location, at any time, without any special equipment, and requires minimal time investment (<xref ref-type="bibr" rid="B5">Chen et al., 2022</xref>). Hence, it is easily incorporated into daily routines and could easily be integrated into a comprehensive CR program.</p>
<p>Moderate intensity continuous aerobic exercise is the most widely researched type of exercise in CR and has been shown to be efficient, safe, and well-tolerated by patients with HF (<xref ref-type="bibr" rid="B19">Molloy et al., 2024-03</xref>). Historically, <italic>Baduanjin</italic> has been considered light-intensity exercise, regardless of the individual&#x2019;s physical fitness. In contrast, our group has recently demonstrated that <italic>Baduanjin</italic> exercise falls within the moderate intensity aerobic exercise classification, based on the percent of measured oxygen consumption (VO<sub>2</sub>), particularly for deconditioned patients such as those with HF (<xref ref-type="bibr" rid="B4">Chen et al., 2020</xref>). However, to date there is a lack of evidence comparing <italic>Baduanjin</italic> with conventional moderate intensity aerobic exercise such as cycle ergometer exercise, among CHF patients. This highlights a key knowledge gap for referring physicians. Therefore, the purpose of this study was to 1) compare the cardiopulmonary responses between <italic>Baduanjin</italic> and cycle ergometer exercise; and 2) compare the hemodynamic responses between <italic>Baduanjin</italic> and cycle ergometer exercise, in patients with CHF.</p>
</sec>
<sec sec-type="methods" id="s2">
<title>2 Methods</title>
<sec id="s2-1">
<title>2.1 Participants</title>
<p>We utilized a cross-sectional design to recruit patients from the chronic disease management cohort at the Heart Failure Center at Guangdong Provincial Hospital of Chinese Medicine, between June 2023 and January 2024. Eligible participants included stable heart failure patients aged 18&#x2013;85 years, classified as New York Heart Association (NYHA) class II or III, who had practiced <italic>Baduanjin</italic> for at least 3 months. The exclusion criteria for the trial included conditions that contraindicate exercise testing. Inclusion and exclusion criteria details are listed in Supplementary S1.</p>
</sec>
<sec id="s2-2">
<title>2.2 Data collection</title>
<sec id="s2-2-1">
<title>2.2.1 Procedures, equipment, and requirements</title>
<p>Our study was conducted in the CR department at the Heart Failure Center at Guangdong Provincial Hospital of Chinese Medicine. The main process of this study included three steps (<xref ref-type="fig" rid="F1">Figure 1</xref>). First, after collecting the baseline information (i.e., medical history, physical examination, anthropometric measurements, and echocardiograph data), we conducted a maximal cardiopulmonary exercise test to determine individual maximal exercise capacity (e.g., VO<sub>2</sub> peak). Second, we conducted a real-time monitoring test of cardiopulmonary and hemodynamic metrics during <italic>Baduanjin</italic> exercise. Third, we conducted a real-time monitoring test of the same cardiopulmonary and hemodynamic metrics during cycle ergometer exercise. Details of data collection were listed in Supplementary S2. All of the hemodynamic data collected and constructed by PhysioFlow are listed below with their clinical meanings listed in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Study procedures Legends: NYHA, New York Heart Association; BMI, body mass index; HFrEF, heart failure with reduced ejection fraction; HFmrEF, heart failure with middle ranged ejection fraction; HFpEF, heart failure with perceived ejection fraction; VO<sub>2</sub>, volume of Oxygen; EqualVO2, the average oxygen consumption; CPET, cardiopulmonary exercise testing.</p>
</caption>
<graphic xlink:href="fphys-16-1620785-g001.tif">
<alt-text content-type="machine-generated">Flowchart comparing cardiopulmonary and hemodynamic responses to Baduanjin and cycle ergometer exercises in chronic heart failure patients. It involves enrollment, preparation, two exercises, and data collection. Exercise 1 is a 9-minute Baduanjin session; Exercise 2 is a cycle ergometer exercise adjusted to Equal VO2. Data on CPET parameters and hemodynamics are recorded continuously. The chart includes participant demographics and baseline information.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec id="s2-3">
<title>2.3 Statistical analysis</title>
<p>We adopted statistical analyses similar to those described in our previous work (<xref ref-type="bibr" rid="B4">Chen et al., 2020</xref>). Data from the maximal exercise test as well as the average cardiorespiratory and hemodynamic parameters obtained during <italic>Baduanjin</italic> exercise and cycle ergometer exercise were summarized as mean and standard deviation (SD). The mean VO<sub>2</sub> and HR collected during <italic>Baduanjin</italic> exercise and cycle ergometer exercise were compared to individual maximum exercise capacity measured during the cardiopulmonary exercise test and reported as a percentage (expressed as %VO<sub>2max</sub> and %HR<sub>max</sub>). In order to categorize the exercise intensity, we referred to a position statement on exercise intensity terminology (<xref ref-type="bibr" rid="B20">Norton et al., 2010</xref>). Moreover, in order to explore the cardiopulmonary response patterns throughout the session, all cardiopulmonary parameters were summarized at 10-s intervals as mean &#xb1; SD, and plotted over time. All statistical procedures were performed with SPSS (version 18.0, Chicago, IL, USA).</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 Participant characteristics</title>
<p>The participants (n &#x3d; 30, 29 male and 1 female, ages 61.1 &#xb1; 11.0 years) had a clinical history of heart failure for a median of 3.5 years and were classified as either New York Heart Association (NYHA) II (n &#x3d; 19, 63.3%) or NYHA III (n &#x3d; 11, 36.7%). The mean left ventricular ejection fraction (LVEF) was 49.4% &#xb1; 13.4%, and they were either with reduced LVEF (HFrEF, n &#x3d; 9, 30.0%), middle ranged LVEF (HFmrEF, n &#x3d; 7, 23.3%), or preserved LVEF n (HFpEF, n &#x3d; 14, 46.7%). In addition, 96.7% of the participants (n &#x3d; 29) had been taking &#x3b2;-blockers. Spirometry showed that 66.7% (n &#x3d; 20) of participants had normal lung function; and 26.7% (n &#x3d; 8), 3.3% (n &#x3d; 1), and 3.3% (n &#x3d; 1) showed restrictive, obstructive, and mixed pulmonary ventilatory dysfunction, respectively. Details on demographic and anthropometry characteristics, medical history, heart failure status, and comorbidities are presented in <xref ref-type="table" rid="T2">Table 2</xref>.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Cardiopulmonary and hemodynamic parameters collected in this study.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th colspan="4" align="left">A. Hemodynamic parameters</th>
</tr>
<tr>
<th align="left"/>
<th align="left">Parameters</th>
<th align="left">Abbreviations</th>
<th align="left">Clinical meaning</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="2" align="left">Left Ventricular Ejection Function</td>
<td align="left">Stroke Volume</td>
<td align="left">SV (mL)</td>
<td align="left">The amount of blood pumped out by the heart with each contraction</td>
</tr>
<tr>
<td align="left">Cardiac Output</td>
<td align="left">CO (L/min)</td>
<td align="left">The amount of blood the heart pumps per minute, CO &#x3d; SV &#x2a; HR</td>
</tr>
<tr>
<td align="left">Myocardial Contraction</td>
<td align="left">Contractility Index</td>
<td align="left">CI</td>
<td align="left">An index to evaluate heart contraction function</td>
</tr>
<tr>
<td align="left">Preload</td>
<td align="left">Early Diastolic Filling Rate</td>
<td align="left">EDFR (%)</td>
<td align="left">The rate of left ventricular filling in the early diastolic phase</td>
</tr>
<tr>
<td align="left">Afterload</td>
<td align="left">Systemic Vascular Resistance</td>
<td align="left">SVR (dyn&#x2219;s/cm<sup>5</sup>)</td>
<td align="left">The systemic peripheral vessels&#x2019; resistance to cardiac pumping</td>
</tr>
<tr>
<td align="left">Peripheral oxygen utilization</td>
<td align="left">Arterial-venous oxygen difference</td>
<td align="left">C<sub>(a-v)</sub>O<sub>2</sub> (mL/dL)</td>
<td align="left">The difference in oxygen content between arterial and venous blood, reflecting the balance between oxygen delivery and consumption at the tissue level</td>
</tr>
<tr>
<td colspan="4" align="left">B. Cardiopulmonary parameters</td>
</tr>
<tr>
<td rowspan="5" align="left">Exercise Tolerance</td>
<td align="left">Load</td>
<td align="left">Load (W)</td>
<td align="left">The load imposed on the body during exercise</td>
</tr>
<tr>
<td align="left">Maximum Oxygen Consumption</td>
<td align="left">VO<sub>2max</sub> (mL/kg/min)</td>
<td align="left">The amount of oxygen consumed per minute during maximum intensity exercise</td>
</tr>
<tr>
<td align="left">Anaerobic Threshold</td>
<td align="left">AT</td>
<td align="left">The critical point at which anaerobic metabolism exceeds aerobic metabolism during exercise</td>
</tr>
<tr>
<td align="left">Respiratory Exchange Ratio</td>
<td align="left">RER</td>
<td align="left">The ratio of carbon dioxide production to oxygen consumption during respiration</td>
</tr>
<tr>
<td align="left">Metabolic Equivalents</td>
<td align="left">METs</td>
<td align="left">The multiple of metabolic rate during exercise compared to the rate at rest, indicating the relative energy metabolism level</td>
</tr>
<tr>
<td rowspan="6" align="left">Circulatory Function</td>
<td align="left">Heart Rate</td>
<td align="left">HR (bpm)</td>
<td align="left">The number of heart beats per minute</td>
</tr>
<tr>
<td align="left">Maximum Heart Rate</td>
<td align="left">HR<sub>max</sub> (bpm)</td>
<td align="left">The highest heart rate that can be achieved during maximum exercise intensity</td>
</tr>
<tr>
<td align="left">Oxygen Pulse</td>
<td align="left">O<sub>2pulse</sub> (ml/beat)</td>
<td align="left">The amount of oxygen consumed by the body per heartbeat, calculated from VO<sub>2</sub>/HR</td>
</tr>
<tr>
<td align="left">Systolic Blood Pressure</td>
<td align="left">SBP (mmHg)</td>
<td align="left">Blood pressure value during heart contraction</td>
</tr>
<tr>
<td align="left">Diastolic Blood Pressure</td>
<td align="left">DBP (mmHg)</td>
<td align="left">Blood pressure value during heart relaxation</td>
</tr>
<tr>
<td align="left">1-min Heart Rate Recovery</td>
<td align="left">HRR<sub>1</sub> (bpm)</td>
<td align="left">An index of parasympathetic activity</td>
</tr>
<tr>
<td rowspan="2" align="left">Ventilation Function</td>
<td align="left">Minute Ventilation</td>
<td align="left">V<sub>E</sub> (L/min)</td>
<td align="left">The amount of gas exhaled per minute</td>
</tr>
<tr>
<td align="left">Respiratory Rate</td>
<td align="left">RR (bpm)</td>
<td align="left">The number of breaths per minute</td>
</tr>
<tr>
<td rowspan="3" align="left">Gas Exchange</td>
<td align="left">End-Tidal Carbon Dioxide Pressure</td>
<td align="left">P<sub>ET</sub>CO<sub>2</sub> (mmHg)</td>
<td align="left">The carbon dioxide pressure in the terminal airways during exhalation</td>
</tr>
<tr>
<td align="left">Ventilation/Carbon Dioxide Production</td>
<td align="left">V<sub>E</sub>/VCO<sub>2</sub>
</td>
<td align="left">The ratio of ventilation per carbon dioxide production</td>
</tr>
<tr>
<td align="left">Ventilation/Carbon Dioxide Production Slope</td>
<td align="left">V<sub>E</sub>/VCO<sub>2</sub> slope</td>
<td align="left">The rate of increase in ventilation per unit increase in carbon dioxide production</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Participants&#x2019; characteristics (n &#x3d; 30).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Parameters</th>
<th align="left">Mean &#xb1; SD or number (%) (n &#x3d; 30)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td colspan="2" align="left">Demographic and anthropometrical characteristics</td>
</tr>
<tr>
<td align="left">&#x2003;Male</td>
<td align="left">29 (96.7%)</td>
</tr>
<tr>
<td align="left">&#x2003;Age, years</td>
<td align="left">61.1 &#xb1; 11.0</td>
</tr>
<tr>
<td align="left">&#x2003;BMI</td>
<td align="left">23.9 &#xb1; 3.1</td>
</tr>
<tr>
<td align="left">&#x2003;Smoker</td>
<td align="left">10 (33.3%)</td>
</tr>
<tr>
<td align="left">&#x2003;Drinker</td>
<td align="left">5 (16.7%)</td>
</tr>
<tr>
<td colspan="2" align="left">Heart failure characteristics</td>
</tr>
<tr>
<td align="left">&#x2003;Heart failure history, years</td>
<td align="left">3.5 (2.0, 6.0) <sup>&#x25b2;</sup>
</td>
</tr>
<tr>
<td align="left">&#x2003;NYHA classification</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;&#x2003;- NYHA II</td>
<td align="left">19 (63.3%)</td>
</tr>
<tr>
<td align="left">&#x2003;&#x2003;- NYHA III</td>
<td align="left">11 (36.7%)</td>
</tr>
<tr>
<td align="left">&#x2003;LVEF classification</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;&#x2003;-HFrEF</td>
<td align="left">9 (30.0%)</td>
</tr>
<tr>
<td align="left">&#x2003;&#x2003;-HFmrEF</td>
<td align="left">7 (23.3%)</td>
</tr>
<tr>
<td align="left">&#x2003;&#x2003;-HFpEF</td>
<td align="left">14 (46.7%)</td>
</tr>
<tr>
<td align="left">&#x2003;HR, bpm&#x2a;</td>
<td align="left">67.7 &#xb1; 10.8</td>
</tr>
<tr>
<td align="left">&#x2003;SBP, mmHg&#x2a;</td>
<td align="left">108.8 &#xb1; 14.1</td>
</tr>
<tr>
<td align="left">&#x2003;DBP, mmHg&#x2a;</td>
<td align="left">66.8 &#xb1; 9.8</td>
</tr>
<tr>
<td align="left">&#x2003;NT-proBNP, pg/mL</td>
<td align="left">394.0 (189.5,855.1) <sup>&#x25b2;</sup>
</td>
</tr>
<tr>
<td align="left">&#x2003;LVEF, %</td>
<td align="left">49.4 &#xb1; 13.4</td>
</tr>
<tr>
<td align="left">&#x2003;PASP, mmHg</td>
<td align="left">25.2 &#xb1; 5.9</td>
</tr>
<tr>
<td align="left">&#x2003;&#x3b2;-blocker users</td>
<td align="left">29 (96.7%)</td>
</tr>
<tr>
<td colspan="2" align="left">Comorbidities</td>
</tr>
<tr>
<td align="left">&#x2003;Coronary heart disease</td>
<td align="left">21 (70.0%)</td>
</tr>
<tr>
<td align="left">&#x2003;Previous MI</td>
<td align="left">12 (40.0%)</td>
</tr>
<tr>
<td align="left">&#x2003;Atrial fibrillation</td>
<td align="left">6 (20.0%)</td>
</tr>
<tr>
<td align="left">&#x2003;Hypertension</td>
<td align="left">14 (46.7%)</td>
</tr>
<tr>
<td align="left">&#x2003;Type 2 diabetes</td>
<td align="left">14 (46.7%)</td>
</tr>
<tr>
<td align="left">&#x2003;Chronic kidney disease</td>
<td align="left">7 (23.3%)</td>
</tr>
<tr>
<td align="left">&#x2003;Peripheral vascular disease</td>
<td align="left">14 (46.7%)</td>
</tr>
<tr>
<td colspan="2" align="left">Lung function</td>
</tr>
<tr>
<td align="left">&#x2003;FVC(%)</td>
<td align="left">84.2 &#xb1; 11.7</td>
</tr>
<tr>
<td align="left">&#x2003;FEV<sub>1</sub> (%)</td>
<td align="left">84.9 &#xb1; 10.5</td>
</tr>
<tr>
<td align="left">&#x2003;FEV<sub>1</sub>/FVC(%)</td>
<td align="left">105.2 &#xb1; 7.4</td>
</tr>
<tr>
<td align="left">&#x2003;MVV(%)</td>
<td align="left">96.6 &#xb1; 17.5</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>
<sup>&#x25b2;</sup>
<italic>Median</italic> (<italic>P</italic>
<sub>25</sub>, <italic>P</italic>
<sub>75</sub>).</p>
</fn>
<fn>
<p>&#x2a;Collected by the research nurse using an electronic sphygmomanometer as the baseline information.</p>
</fn>
<fn>
<p>Abbreviations: bpm, beats per minute; BMI, body mass index; DBP, diastolic blood pressure; EF, ejection fraction; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; HFrEF, heart failure with reduced ejection fraction; HFmrEF, heart failure with middle ranged ejection fraction; HFpEF, heart failure with perceived ejection fraction; HR, heart rate; LVEF, left ventricular ejection fraction; MI, myocardial infarction; MVV, maximum voluntary ventilation; NYHA, new york heart association; NT-proBNP, N-terminal B-type natriuretic peptide; PASP, pulmonary artery systolic pressure; SBP, systolic blood pressure; SD, standard deviation.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-2">
<title>3.2 Results of maximum exercise tests and resting hemodynamic status</title>
<p>As shown in <xref ref-type="table" rid="T3">Table 3</xref>, the results of the maximum exercise test revealed that the average RER of the 30 participants was 1.1 &#xb1; 0.1. All participants stopped testing due to leg muscle fatigue. VT was detected in all cases. Participants had an impaired exercise capacity with a mean VO<sub>2max</sub> of 18.4 &#xb1; 4.2 mL/kg/min and demonstrated an elevated V<sub>E</sub>/VCO<sub>2</sub> slope (30.8 &#xb1; 5.8).</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Ventilation and gas exchange data during maximal exercise and resting hemodynamic data.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Parameters</th>
<th align="center">Values (Mean &#xb1; SD)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Load (W)_MAX</td>
<td align="center">91.7 &#xb1; 30.4</td>
</tr>
<tr>
<td colspan="2" align="left">A. Ventilation and Gas Exchange during maximal exercise</td>
</tr>
<tr>
<td align="left">Maximum RER</td>
<td align="center">1.1 &#xb1; 0.1</td>
</tr>
<tr>
<td align="left">Maximum VO<sub>2</sub> (mL/kg/min)</td>
<td align="center">18.4 &#xb1; 4.2</td>
</tr>
<tr>
<td align="left">Maximum METS</td>
<td align="center">5.2 &#xb1; 1.2</td>
</tr>
<tr>
<td align="left">Maximum RR (bpm)</td>
<td align="center">33.4 &#xb1; 5.0</td>
</tr>
<tr>
<td align="left">Maximum V<sub>E</sub> (L/min)</td>
<td align="center">48.1 &#xb1; 10.4</td>
</tr>
<tr>
<td align="left">Maximum P<sub>ET</sub>CO<sub>2</sub> (mmHg)</td>
<td align="center">37.4 &#xb1; 5.6</td>
</tr>
<tr>
<td align="left">VE/VCO<sub>2</sub> slope<sup>&#x25b3;</sup>
</td>
<td align="center">30.8 &#xb1; 5.8</td>
</tr>
<tr>
<td colspan="2" align="left">B. Hemodynamics during rest</td>
</tr>
<tr>
<td align="left">Resting HR (bpm)&#x2a;</td>
<td align="center">70.2 &#xb1; 8.2</td>
</tr>
<tr>
<td align="left">Resting SV (mL)</td>
<td align="center">76.6 &#xb1; 14.4</td>
</tr>
<tr>
<td align="left">Resting CO (L/min)</td>
<td align="center">5.2 &#xb1; 1.1</td>
</tr>
<tr>
<td align="left">Resting CI</td>
<td align="center">152.8 &#xb1; 54.6</td>
</tr>
<tr>
<td align="left">Resting O<sub>2</sub> pulse (mL/beat)</td>
<td align="center">4.3 &#xb1; 1</td>
</tr>
<tr>
<td align="left">Resting EDFR (%)</td>
<td align="center">63.6 (49.4, 71.4)<sup>&#x25b2;</sup>
</td>
</tr>
<tr>
<td align="left">Resting SBP (mmHg)&#x2a;</td>
<td align="center">117.3 &#xb1; 22</td>
</tr>
<tr>
<td align="left">Resting DBP (mmHg)&#x2a;</td>
<td align="center">73.3 &#xb1; 17.8</td>
</tr>
<tr>
<td align="left">Resting SVR (dyn&#x2219;s/cm<sup>5</sup>)</td>
<td align="center">2202.0 (1948.0, 2376.0)<sup>&#x25b2;</sup>
</td>
</tr>
<tr>
<td align="left">Resting C<sub>(a-v)</sub>O<sub>2</sub> (mL/dL)</td>
<td align="center">5.18 &#xb1; 2.2</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>
<sup>&#x25b2;</sup>
<italic>Median</italic> (<italic>P</italic>
<sub>25</sub>, <italic>P</italic>
<sub>75</sub>).</p>
</fn>
<fn>
<p>
<sup>&#x25b3;</sup>from rest to maximum.</p>
</fn>
<fn>
<p>&#x2a;Collected during the &#x201c;Maximal exercise test&#x201d;.</p>
</fn>
<fn>
<p>Abbreviations: bpm, beats per minute; CI, contractility index; CO, cardiac output; C<sub>(a-v)</sub>O<sub>2</sub>, arterial-venous oxygen difference; DBP, diastolic blood pressure; EDFR, early diastolic filling rate; HR, heart rate; MAX, maximal intensity; METs, metabolic equivalents; O<sub>2</sub> pulse, oxygen pulse (oxygen consumption to heart rate ratio); P<sub>ET</sub>CO<sub>2</sub>, end-tidal carbon dioxide partial pressure; RR, respiratory rate; RER, respiratory exchange ratio; SBP, systolic blood pressure; SD, standard deviation; SV, stroke volume; SVR, systemic vascular resistance; V<sub>E</sub>, minute ventilation; V<sub>E</sub>/VCO<sub>2</sub> slope, ventilation efficiency for carbon dioxide elimination; VO<sub>2</sub>, oxygen consumption.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The results of hemodynamic assessment indicated that this sample exhibited normal resting SV at 76.6 &#xb1; 14.4 mL, CO at 5.2 &#xb1; 1.1 L/min, C<sub>(a-v)</sub>O<sub>2</sub> at 5.18 &#xb1; 2.2 mL/dL, and SVR with a median of 2,202.0 dyn&#x2219;s/cm<sup>5</sup>. Additional details regarding hemodynamic indices are presented in <xref ref-type="table" rid="T3">Table 3</xref>.</p>
</sec>
<sec id="s3-3">
<title>3.3 Comparison of the average cardiopulmonary and hemodynamic responses between <italic>Baduanjin</italic> exercise and cycle ergometer exercise</title>
<p>For the average cardiopulmonary responses (<xref ref-type="table" rid="T4">Table 4</xref>), the intensity of the two exercises are similar. During exercise, the average VO<sub>2</sub> during <italic>Baduanjin</italic> was 44.6% of VO<sub>2max</sub> compared to 45.7% of VO<sub>2max</sub> during cycling with no statistically significant difference between the two groups (8.2 &#xb1; 1.3 vs. 8.4 &#xb1; 1.4, <italic>p</italic> &#x3d; 0.339, respectively; <xref ref-type="table" rid="T4">Table 4</xref>). For ventilatory and metabolic measures, <italic>Baduanjin</italic> demonstrated significantly lower RR, V<sub>E</sub>, P<sub>ET</sub>CO<sub>2</sub>, and V<sub>E/</sub>VCO<sub>2</sub> (all <italic>P</italic> &#x3c; 0.001), compared to the cycling exercise (<xref ref-type="table" rid="T4">Table 4</xref>).</p>
<table-wrap id="T4" position="float">
<label>TABLE 4</label>
<caption>
<p>Comparison of cardiopulmonary and hemodynamic responses to <italic>Baduanjin</italic> exercise or cycle exercise.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Parameters</th>
<th align="left">
<italic>Baduanjin</italic> (Mean &#xb1; SD)</th>
<th align="left">Cycling (Mean &#xb1; SD)</th>
<th align="left">
<italic>P</italic>-value</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Load (W)</td>
<td align="left">&#x2014;</td>
<td align="left">21.9 &#xb1; 8.4</td>
<td align="left">-</td>
</tr>
<tr>
<td colspan="4" align="left">A. Ventilation and Gas Exchange</td>
</tr>
<tr>
<td align="left">VO<sub>2</sub> (mL/kg/min)</td>
<td align="left">8.2 &#xb1; 1.3</td>
<td align="left">8.4 &#xb1; 1.4</td>
<td align="left">0.339</td>
</tr>
<tr>
<td align="left">METs</td>
<td align="left">2.3 &#xb1; 0.4</td>
<td align="left">2.4 &#xb1; 0.4</td>
<td align="left">0.299</td>
</tr>
<tr>
<td align="left">RR (bpm)</td>
<td align="left">21.1 &#xb1; 4.6</td>
<td align="left">23.2 &#xb1; 3.3</td>
<td align="left">0.003&#x2a;</td>
</tr>
<tr>
<td align="left">V<sub>E</sub> (L/min)</td>
<td align="left">18.8 &#xb1; 4.5</td>
<td align="left">21.3 &#xb1; 3.9</td>
<td align="left">&#x3c;0.001&#x2a;</td>
</tr>
<tr>
<td align="left">P<sub>ET</sub>CO<sub>2</sub> (mmHg)</td>
<td align="left">31.6 &#xb1; 3.2</td>
<td align="left">34.0 &#xb1; 3.4</td>
<td align="left">&#x3c;0.001&#x2a;</td>
</tr>
<tr>
<td align="left">V<sub>E/</sub>VCO<sub>2</sub>
</td>
<td align="left">39.5 &#xb1; 5.4</td>
<td align="left">42.0 &#xb1; 5.4</td>
<td align="left">&#x3c;0.001&#x2a;</td>
</tr>
<tr>
<td colspan="4" align="left">B. Hemodynamics</td>
</tr>
<tr>
<td align="left">HR (bpm)</td>
<td align="left">81.8 &#xb1; 9.7</td>
<td align="left">79.9 &#xb1; 10.2</td>
<td align="left">0.005&#x2a;</td>
</tr>
<tr>
<td align="left">HR<sub>max</sub> (bpm)</td>
<td align="left">93.9 &#xb1; 12.0</td>
<td align="left">86.0 &#xb1; 11.9</td>
<td align="left">&#x3c;0.001&#x2a;</td>
</tr>
<tr>
<td align="left">HRR<sub>1</sub> (bpm)</td>
<td align="left">5.0 (2.0, 8.0)<sup>&#x25b2;</sup>
</td>
<td align="left">5.0 (3.0, 8.0)<sup>&#x25b2;</sup>
</td>
<td align="left">0.343</td>
</tr>
<tr>
<td align="left">SV (mL)</td>
<td align="left">64.5 &#xb1; 11.3</td>
<td align="left">70.9 &#xb1; 10.4</td>
<td align="left">0.001&#x2a;</td>
</tr>
<tr>
<td align="left">CO (L/min)</td>
<td align="left">5.2 &#xb1; 0.8</td>
<td align="left">5.6 &#xb1; 0.9</td>
<td align="left">0.017&#x2a;</td>
</tr>
<tr>
<td align="left">CI</td>
<td align="left">145.9 &#xb1; 57.8</td>
<td align="left">176.9 &#xb1; 63.4</td>
<td align="left">&#x3c;0.001&#x2a;</td>
</tr>
<tr>
<td align="left">O<sub>2</sub> pulse (ml/beat)</td>
<td align="left">6.8 &#xb1; 1.5</td>
<td align="left">7.2 &#xb1; 1.4</td>
<td align="left">0.001&#x2a;</td>
</tr>
<tr>
<td align="left">EDFR (%)</td>
<td align="left">60.1 (56.4, 68.2)<sup>&#x25b2;</sup>
</td>
<td align="left">59.5 (53.1, 69.6)<sup>&#x25b2;</sup>
</td>
<td align="left">0.586</td>
</tr>
<tr>
<td align="left">SBP (mmHg)</td>
<td align="left">109.1 &#xb1; 16.4</td>
<td align="left">113.1 &#xb1; 15.7</td>
<td align="left">0.021&#x2a;</td>
</tr>
<tr>
<td align="left">DBP (mmHg)</td>
<td align="left">65.9 &#xb1; 8.1</td>
<td align="left">65.9 &#xb1; 10.1</td>
<td align="left">0.544</td>
</tr>
<tr>
<td align="left">SVR (dyn&#x2219;s/cm<sup>5</sup>)</td>
<td align="left">1,451.4 (1,198.7, 1663.7)<sup>&#x25b2;</sup>
</td>
<td align="left">1,140.1 (1,040.9, 1220.9)<sup>&#x25b2;</sup>
</td>
<td align="left">&#x3c;0.001&#x2a;</td>
</tr>
<tr>
<td align="left">C<sub>(a-v)</sub>O<sub>2</sub> (mL/dL)</td>
<td align="left">11.2 &#xb1; 3.5</td>
<td align="left">10.4 &#xb1; 2.6</td>
<td align="left">0.036&#x2a;</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>
<sup>&#x25b2;</sup>
<italic>Median</italic> (<italic>P</italic>
<sub>25</sub>,<italic>P</italic>
<sub>75</sub>).</p>
</fn>
<fn>
<p>Abbreviations: bpm, beats per minute; C<sub>(a-v)</sub>O<sub>2</sub>, arterial-venous oxygen difference; CI, contractility index; CO, cardiac output; DBP, diastolic blood pressure; EDFR, early-diastolic filling rate; HR, heart rate; HR<sub>max</sub>, maximum heart rate during exercise; HRR<sub>1</sub>, 1-min heart rate recovery; METs, metabolic equivalents; O<sub>2</sub> pulse, oxygen pulse (oxygen consumption to heart rate ratio); P<sub>ET</sub>CO<sub>2</sub>, end-tidal carbon dioxide partial pressure; RR, respiratory rate; SBP, systolic blood pressure; SD, standard deviation; SV, stroke volume; SVR, systemic vascular resistance; V<sub>E</sub>, minute ventilation; V<sub>E</sub>/VCO<sub>2</sub> slope, ventilation efficiency for carbon dioxide elimination; VO<sub>2</sub>, oxygen consumption.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>For the average hemodynamic responses (<xref ref-type="table" rid="T4">Table 4</xref>), the average HR during <italic>Baduanjin</italic> exercise was significantly higher when compared to cycling (<xref ref-type="table" rid="T4">Table 4</xref>). Similarly, the peak heart rate during <italic>Baduanjin</italic> was significantly higher than during cycle exercise (93.9 bpm <italic>versus</italic> 86.0 bpm, <italic>P</italic> &#x3c; 0.001, <xref ref-type="table" rid="T4">Table 4</xref>). Furthermore, our data indicate that SBP was significantly lower during <italic>Baduanjin</italic> compared to cycling while DBP was not different between the two activities (<xref ref-type="table" rid="T4">Table 4</xref>). In addition, the average SV and CO during <italic>Baduanjin</italic> exercise (SV: 64.5 &#xb1; 11.3 mL, CO: 5.2 &#xb1; 0.8 L/min) were both significantly lower than cycle exercise (SV: 70.9 &#xb1; 10.4 mL, <italic>P</italic> &#x3d; 0.001; CO: 5.6 &#xb1; 0.9 L/min, <italic>P</italic> &#x3d; 0.017). Moreover, significantly higher C<sub>(a-v)</sub>O<sub>2</sub> (<italic>P</italic> &#x3d; 0.036) and SVR (<italic>P</italic> &#x3d; 0.036) were found during <italic>Baduanjin</italic> exercise than during cycle exercise.</p>
</sec>
<sec id="s3-4">
<title>3.4 Comparison of the real-time cardiopulmonary and hemodynamic responses between <italic>Baduanjin</italic> exercise and cycle ergometer exercise</title>
<p>The VO<sub>2</sub> responses are shown in <xref ref-type="fig" rid="F2">Figures 2a,b</xref>. The VO<sub>2</sub> response curve of the cycle exercise is smooth with no obvious peaks. After the cycle ergometer exercise reached moderate intensity in the second minute, it leveled off and remained at moderate intensity. However, the fluctuations in VO<sub>2</sub> during the <italic>Baduanjin</italic> exercise are greater than those during the cycle exercise. The VO<sub>2</sub> responses exhibited a bimodal distribution during <italic>Baduanjin</italic>. The VO<sub>2</sub> increased during the first 3 min when a hemi-squat posture was involved (second posture), followed by a small drop in VO<sub>2</sub> after the transition to third posture. The intensity reached the second peak at the seventh minute during an additional two hemi-squat postures (fifth and seventh). It then dropped to the baseline during the resting phase. Overall, the absolute VO<sub>2</sub> response remained under the VT (<xref ref-type="fig" rid="F2">Figure 2a</xref>) and the %VO<sub>2max</sub> response remained within the moderate-intensity range (<xref ref-type="fig" rid="F2">Figure 2b</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Comparison of the real-time cardiopulmonary responses of <bold>(a)</bold> VO<sub>2</sub>max, <bold>(b)</bold> %VO<sub>2</sub>max, <bold>(c)</bold> HR, and <bold>(d)</bold> %HRmax between Baduanjin exercise and cycle ergometer exercise.</p>
</caption>
<graphic xlink:href="fphys-16-1620785-g002.tif">
<alt-text content-type="machine-generated">Graphs comparing Baduanjin and cycling effects. (a) VO&#x2082;max measures peak point slightly higher in cycling. (b) %VO&#x2082;max has higher values for cycling. (c) Heart rate (HR) shows moderate increases in both activities. (d) %HRmax indicates higher levels for cycling compared to Baduanjin. Time span is from 0 to 9 minutes, with activity thresholds marked.</alt-text>
</graphic>
</fig>
<p>The HR responses are shown in <xref ref-type="fig" rid="F2">Figures 2c,d</xref>. Similar to the VO2 response, the HR response was smooth during cycle exercise and exhibited a bimodal distribution with smaller magnitudes during <italic>Baduanjin</italic> (<xref ref-type="fig" rid="F2">Figures 2c,d</xref>). Overall, the absolute HR response remained under the equivalent HR for the VT (<xref ref-type="fig" rid="F2">Figure 2c</xref>) and the %HRmax response remained within the moderate-intensity range (<xref ref-type="fig" rid="F2">Figure 2d</xref>).</p>
<p>
<xref ref-type="fig" rid="F3">Figure 3</xref> shows the participants&#x2019; ventilatory responses, including respiratory rate (<xref ref-type="fig" rid="F3">Figure 3a</xref>), V<sub>E</sub> (<xref ref-type="fig" rid="F3">Figure 3b</xref>), P<sub>ET</sub>CO<sub>2</sub> (<xref ref-type="fig" rid="F3">Figure 3c</xref>), and V<sub>E</sub>/VCO<sub>2</sub> (<xref ref-type="fig" rid="F3">Figure 3d</xref>), during <italic>Baduanjin</italic> and cycling exercise. All three response lines from <italic>Baduanjin</italic> were lower than those from cycling.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Comparison of the real-time pulmonary responses of <bold>(a)</bold> respiratory rate, <bold>(b)</bold> minute ventilation, <bold>(c)</bold> end-tidal carbon dioxide partial pressure, and <bold>(d)</bold> V<sub>E</sub>/VCO<sub>2</sub> between Baduanjin exercise and cycle ergometer exercise.</p>
</caption>
<graphic xlink:href="fphys-16-1620785-g003.tif">
<alt-text content-type="machine-generated">Four line graphs compare Baduanjin and cycling on: a) Respiratory Rate (brpm), b) Minute Ventilation (L/min), c) End-tidal Carbon Dioxide Pressure (mmHg), and d) \(V_E/VCO_2\). Each graph displays trends over time from 0 to 9 minutes, with Baduanjin and cycling depicted in blue and purple lines, respectively. Error bars indicate variability.</alt-text>
</graphic>
</fig>
<p>
<xref ref-type="fig" rid="F4">Figure 4</xref> illustrates the real-time hemodynamic responses during <italic>Baduanjin</italic> and cycle exercise. Overall, during cycling, hemodynamics initially increased from a low value and then stabilized, while <italic>Baduanjin</italic>&#x2019;s SV and CO response lines showed fluctuations with time and movement changes. Compared to cycle exercise, the SV and CO response were both lower during <italic>Baduanjin</italic> (<xref ref-type="fig" rid="F4">Figures 4a,b</xref>), while the C<sub>(a-v)</sub>O<sub>2</sub> and SVR response was higher during <italic>Baduanjin</italic> (<xref ref-type="fig" rid="F4">Figures 4c,d</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Comparison of the real-time hemodynamic responses of <bold>(a)</bold> stroke volume, <bold>(b)</bold> cardiac output, <bold>(c)</bold> arterial-venous oxygen difference, and <bold>(d)</bold> systemic vascular resistance between Baduanjin exercise and cycle ergometer exercise.</p>
</caption>
<graphic xlink:href="fphys-16-1620785-g004.tif">
<alt-text content-type="machine-generated">Four line graphs compare the effects of Baduanjin and cycling exercises over nine minutes. Graph a shows stroke volume in milliliters, with higher levels for cycling. Graph b presents cardiac output in liters per minute, with cycling again higher. Graph c depicts arterial-venous oxygen difference in milliliters per deciliter, showing slight increases for both activities. Graph d illustrates systemic vascular resistance in dynes per second per square centimeter, with Baduanjin higher than cycling.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>4 Discussion</title>
<p>This is the first study to compare chronic heart failure patients&#x2019; cardiopulmonary and hemodynamic responses to <italic>Baduanjin</italic> exercise to their responses to constant-load moderate intensity cycle exercise. The intensity of both exercise modalities was calibrated according to VO<sub>2</sub>, resulting in comparable average VO<sub>2</sub> for each modality. In terms of the cardiopulmonary response, <italic>Baduanjin</italic> exercise is characterized by a bimodal distribution of VO<sub>2</sub> responses as well as a lower respiratory burden, which is associated with greater ventilatory efficiency compared to conventional cycling. In terms of hemodynamic response, <italic>Baduanjin</italic> is demonstrated significantly lower cardiac output and elevated arterial-venous oxygen difference. These cardiopulmonary and hemodynamic responses to <italic>Baduanjin</italic> may be attributed to a higher degree of muscle engagement compared to cycle ergometer exercise.</p>
<p>The strength of this study lies in its comparison of the cardiopulmonary and hemodynamic differences between <italic>Baduanjin</italic> exercise and cycle exercise during matched intensity levels. Our study suggests that <italic>Baduanjin</italic> is a moderate-intensity aerobic exercise suitable for CHF patients, similar to our prior findings (<xref ref-type="bibr" rid="B4">Chen et al., 2020</xref>). However, there is a lack of research on real-time physiological responses comparing these two exercise modalities. When studying the cardiopulmonary and hemodynamic responses to different exercises, maintaining a consistent intensity level is crucial (<xref ref-type="bibr" rid="B26">Taylor et al., 2021</xref>). In a previous study, exercise intensity was matched based on heart rate response (<xref ref-type="bibr" rid="B13">Gary et al., 2019</xref>), while in this study, mean VO<sub>2</sub> during <italic>Baduanjin</italic> exercise was used for match intensity. As such, there was no significant difference in average VO<sub>2</sub> between the two modes of exercise. This suggests that VO<sub>2</sub> as a parameter is a good tool for balancing determining exercise intensity as complexities may arise when using HR due to the HR-modulating effect of pharmacotherapies commonly prescribed for CHF patients, such as &#x3b2;-blockers.</p>
<p>While average VO<sub>2</sub> levels were comparable between the two modes of exercise, distinct differences emerged in the intensity response curves. Cycle exercise plateaued in intensity due to a consistent power output, whereas <italic>Baduanjin</italic> exhibited an intermittent pattern with notable fluctuations, leading to a bimodal response curve. The bimodal VO<sub>2</sub> response observed during <italic>Baduanjin</italic> exercise is a reflection of the unique characteristics of this traditional Chinese practice, likely attributed to its structured sequence of movements with varying intensities. The presence of two VO<sub>2</sub> peaks corresponds to movements involving semi-squat postures, indicating that <italic>Baduanjin</italic> offers a distinctive form of moderate-intensity intermittent training. Moderate-intensity intermittent physical activity has been shown to be associated with improved executive function in older adults (<xref ref-type="bibr" rid="B16">MacDonald et al., 2024</xref>). Furthermore, a systematic review demonstrated that following training, moderate-intensity intermittent training results in greater reductions in fat mass, as well as improved performance on functional tests for elderly women, compared to moderate-intensity continuous training (<xref ref-type="bibr" rid="B8">Coswig et al., 2020/02</xref>). Therefore, <italic>Baduanjin</italic> exercise may be particularly suitable for heart failure patients with impaired executive function or functional performance, as well as for those aiming to achieve fat loss.</p>
<p>
<italic>Baduanjin</italic> exercise imposes a lower respiratory burden by enhancing ventilatory efficiency compared to conventional cycle exercise. Similarly, a meta-analysis has also demonstrated that <italic>Baduanjin</italic> improves ventilatory efficiency (<xref ref-type="bibr" rid="B33">Zou et al., 2017</xref>). Patients with CHF typically exhibit an exaggerated ventilatory response for a given metabolic demand during exercise (<xref ref-type="bibr" rid="B11">Dub&#xe9; et al., 2016-09</xref>). Our study&#x2019;s findings indicate that during <italic>Baduanjin</italic> exercise, the respiratory rate is lower than that observed during cycle exercise at the same intensity, suggesting a more stable exercise-induced respiratory response during <italic>Baduanjin</italic>. This can be particularly advantageous for individuals with heart failure working to improve exercise endurance. In addition, our study show that both V<sub>E</sub> and V<sub>E</sub>/VCO<sub>2</sub> were lower during <italic>Baduanjin</italic> exercise, compared to cycle exercise. V<sub>E</sub> quantifies the total volume of gas inhaled or exhaled per minute and is influenced by respiratory rate and tidal volume. The V<sub>E</sub>/VCO<sub>2</sub> ratio indicates the proportion of ventilation relative to carbon dioxide production. The observed decrease in V<sub>E</sub> and V<sub>E</sub>/VCO<sub>2</sub> during <italic>Baduanjin</italic> exercise suggests that less ventilation is needed for the same amount of carbon dioxide production. This indicates a higher efficiency for gas exchange per breath compared to cycle exercise. <italic>Baduanjin</italic> exercise involves movements that elongate respiratory muscles, enhance thoracic compliance and mobility, reduce respiratory center stimulation, and reduce exertional dyspnea (<xref ref-type="bibr" rid="B30">Xie et al., 2022</xref>). Additionally, it incorporates respiratory muscle and breathing training to increase respiratory muscle strength and endurance, decrease mechanical loads such as chest wall stiffness, and facilitate deeper, slower breathing for improved gas exchange efficiency.</p>
<p>
<italic>Baduanjin</italic> exercise imposes a lower cardiac demand with increased peripheral oxygen utilization, compared to cycling. Our results demonstrate a significantly lower CO response during <italic>Baduanjin</italic> compared with cycling. This reduction in CO, which represents the volume of blood the heart pumps per minute, suggests that <italic>Baduanjin</italic> imposes less cardiac demand than cycling. Moreover, applying the Fick principle, the C<sub>(a-v)</sub>O<sub>2</sub> was significantly higher during <italic>Baduanjin</italic> exercise when compared to the cycling. The C<sub>(a-v)</sub>O<sub>2</sub>., which quantifies the oxygen concentration disparity between arterial and venous blood post-circulation through active muscle, indicates the efficiency with which peripheral organs, tissues, and cells extract oxygen from the mitochondria. Thus, patients engaged in <italic>Baduanjin</italic> exercise may experience improved peripheral oxygen extraction, potentially due to the engagement of multiple muscle groups characteristic of this form of exercise.</p>
<p>
<italic>Baduanjin</italic> has been recognized for its comprehensive muscle training program which targets both the upper and lower extremities. In contrast to cycle exercise, which involves simple movements with less muscle mass engagement, <italic>Baduanjin</italic> incorporates a diverse range of movements that engage muscles throughout the body. For instance, postures such as the horse-riding stance in Postures 2, 5, and 7 can be likened to targeted quadriceps training, effectively strengthening the thigh muscles. Additionally, dynamic movements involving the forearms and fists in Postures 1, 2, 3, and 7 provide comprehensive upper extremity training, enhancing strength and coordination in the arms and hands. Furthermore, <italic>Baduanjin</italic> emphasizes high-impact and weight-bearing exercises, as illustrated in Posture 8 where practitioners push upward from their toes and land forcefully on their feet. Thus, this holistic approach to physical conditioning extends beyond the focus on lower body muscle endurance typically associated with cycle exercise. However, our current data do not allow us to distinguish perfusion changes specifically in the upper or lower extremities. The higher SVR observed during <italic>Baduanjin</italic> compared to that during cycle ergometer exercise may suggest greater muscular engagement, further evidenced by high C<sub>(a-v)</sub>O<sub>2</sub>. Previous research demonstrated that a single bout of resistance training elevates systemic peripheral resistance (<xref ref-type="bibr" rid="B27">Wakeham et al., 2025a</xref>; <xref ref-type="bibr" rid="B28">Wakeham et al., 2025b</xref>; <xref ref-type="bibr" rid="B9">Dawson et al., 1985</xref>; <xref ref-type="bibr" rid="B18">Miles et al., 1987</xref>). Therefore, the engagement of multiple muscle groups in <italic>Baduanjin</italic> contributes to its therapeutic benefits, particularly in expanding practitioners&#x2019; functional capacity and overall muscle strength (<xref ref-type="bibr" rid="B12">Esposito et al., 2011</xref>).</p>
<sec id="s4-1">
<title>4.1 Study limitations</title>
<p>As with any study, this study has potential limitations. Firstly, the sample size was small and we were unable to perform a sample size calculation, as we did not find adequate data for our research question and study design <italic>a priori</italic>. Although the number of participants was low, the within-subject repeats narrowed the estimates&#x2019; confidence intervals. Secondly, the interpretability and generalizability of the results are limited by the analyzed population&#x2019;s clinical characteristics; our study population included mainly NYHA II CHF patients, and only one female. Therefore, our findings are specific to the population studied. Thirdly, our research employed a non-invasive technique known as ICG, which offers benefits for patients. However, ICG also has limitations regarding specific hemodynamic measurements (such as volume and contractility) that need to be estimated or recalculated. Fourthly, it is crucial to recognize that <italic>Baduanjin</italic> exercise encompasses elements of strength training and balance training in addition to endurance exercise training. This multifaceted nature sets <italic>Baduanjin</italic> apart from endurance cycling, which primarily focuses on cardiovascular endurance. As such, the unique combination of strength, balance, and endurance components in <italic>Baduanjin</italic> requires careful consideration when interpreting the results and comparing it to other forms of exercise. Fifth, this study was specifically designed to observe the gas and hemodynamic changes during the two types of exercise. We did not measure the changes in peak VO<sub>2</sub> or VO<sub>2</sub> at the first ventilatory threshold following the two types of exercise in this study. However, these parameters are crucial for reflecting improvements in endurance capacity (<xref ref-type="bibr" rid="B6">Christou et al., 2024</xref>). Comparing these two parameters would be valuable for further elucidating the differences between the two exercises.</p>
</sec>
</sec>
<sec sec-type="conclusion" id="s5">
<title>5 Conclusion</title>
<p>Our study offers novel insight into the cardiopulmonary and hemodynamic differences between <italic>Baduanjin</italic> and cycle ergometer exercise when performed at consistent intensity levels. Unlike the steady intensity of cycle exercise, <italic>Baduanjin</italic> exhibits an intermittent intensity pattern which is the result of more prominent muscle activation during various postures. Additionally, <italic>Baduanjin</italic> is associated with superior improvement in oxygen respiratory efficiency and increased peripheral oxygen utilization, which is crucial to CHF patients&#x2019; health. Furthermore, <italic>Baduanjin</italic> reduces cardiac and respiratory burden, providing a more comfortable exercise experience. From the clinical perspective, the practice&#x2019;s ease-of-use and flexibility regarding time commitment and space requirements make it an attractive option for cardiac rehabilitation programs. Given these advantages, <italic>Baduanjin</italic> would be particularly effective for inclusion in cardiac rehabilitation programs for CHF patients in China, where it is widely practiced and culturally familiar.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec sec-type="ethics-statement" id="s7">
<title>Ethics statement</title>
<p>The research protocol was approved by the Ethics Committee at Guangdong Provincial Hospital of Chinese Medicine under ethical approval number YF2023-119-01. Prior to participation, each subject received an oral explanation of the study and provided written and verbal informed consent.</p>
</sec>
<sec sec-type="author-contributions" id="s8">
<title>Author contributions</title>
<p>XC: Conceptualization, Data curation, Formal Analysis, Methodology, Project administration, Writing &#x2013; original draft, Writing &#x2013; review and editing. XH: Data curation, Formal Analysis, Writing &#x2013; original draft, Writing &#x2013; review and editing. TO: Writing &#x2013; review and editing. YQ: Data curation, Writing &#x2013; review and editing. HZ: Writing &#x2013; review and editing. ZW: Writing &#x2013; review and editing. HC: Funding acquisition, Writing &#x2013; review and editing. WL: Funding acquisition, Writing &#x2013; review and editing. WJ: Conceptualization, Methodology, Project administration, Writing &#x2013; review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s9">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the National Science and Technology Major Project on Prevention and Treatment of Cancer, Cardiovascular and Cerebrovascular, Respiratory and Metabolic Diseases (grant number 2024ZD0522003); and the Clinical Research Funding of Traditional Chinese Medicine Science and Technology (Project 1010) (grant number YN10101910). Guangzhou Basic and Applied Basic Research Foundation (grant number 2024A03J0739).</p>
</sec>
<ack>
<p>The authors wish to thank their research assistant Yunxiang Fan from the Department of Cardiology of Guangdong Provincial Hospital of Chinese Medicine for assistance with collecting data.</p>
</ack>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s11">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="s12">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="s13">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphys.2025.1620785/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphys.2025.1620785/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table2.docx" id="SM2" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balady</surname>
<given-names>G. J.</given-names>
</name>
<name>
<surname>Ades</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Bittner</surname>
<given-names>V. A.</given-names>
</name>
<name>
<surname>Franklin</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>N. F.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>R. J.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: a presidential advisory from the American Heart Association</article-title>. <source>Circulation</source> <volume>124</volume> (<issue>25</issue>), <fpage>2951</fpage>&#x2013;<lpage>2960</lpage>. <pub-id pub-id-type="doi">10.1161/CIR.0b013e31823b21e2</pub-id>
<pub-id pub-id-type="pmid">22082676</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beatty</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Beckie</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Dodson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Kraus</surname>
<given-names>W. E.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>A New era in cardiac rehabilitation delivery: research gaps, questions, strategies, and Priorities</article-title>. <source>Circulation</source> <volume>147</volume> (<issue>3</issue>), <fpage>254</fpage>&#x2013;<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1161/circulationaha.122.061046</pub-id>
<pub-id pub-id-type="pmid">36649394</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bozkurt</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Fonarow</surname>
<given-names>G. C.</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>L. R.</given-names>
</name>
<name>
<surname>Guglin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Josephson</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Forman</surname>
<given-names>D. E.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Cardiac rehabilitation for patients With Heart Failure: JACC Expert Panel</article-title>. <source>J. Am. Coll. Cardiol.</source> <volume>77</volume> (<issue>11</issue>), <fpage>1454</fpage>&#x2013;<lpage>1469</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2021.01.030</pub-id>
<pub-id pub-id-type="pmid">33736829</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Marrone</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Olson</surname>
<given-names>T. P.</given-names>
</name>
<name>
<surname>Lundborg</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Intensity level and cardiorespiratory responses to Baduanjin exercise in patients with chronic heart failure</article-title>. <source>Esc. Heart Fail.</source> <volume>7</volume> (<issue>6</issue>), <fpage>3782</fpage>&#x2013;<lpage>3791</lpage>. <pub-id pub-id-type="doi">10.1002/ehf2.12959</pub-id>
<pub-id pub-id-type="pmid">32902179</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Salazar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Traditional Baduanjin exercise through the eyes of patients with chronic heart failure: a qualitative content analysis study</article-title>. <source>Front. Cardiovasc Med.</source> <volume>9</volume>, <fpage>1049036</fpage>. <pub-id pub-id-type="doi">10.3389/fcvm.2022.1049036</pub-id>
<pub-id pub-id-type="pmid">36684583</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Christou</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Christou</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Davos</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Markozannes</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Christou</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Mantzoukas</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Ergophysiological evaluation of heart failure patients with reduced ejection fraction undergoing exercise-based cardiac rehabilitation: a systematic review and meta-analysis</article-title>. <source>Hell. J. Cardiol.</source> <volume>77</volume>, <fpage>106</fpage>&#x2013;<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1016/j.hjc.2024.01.004</pub-id>
<pub-id pub-id-type="pmid">38246276</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Conraads</surname>
<given-names>V. M.</given-names>
</name>
<name>
<surname>Deaton</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Piotrowicz</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Santaularia</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Tierney</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Piepoli</surname>
<given-names>M. F.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Adherence of heart failure patients to exercise: barriers and possible solutions: a position statement of the study group on exercise training in heart failure of the heart failure association of the European Society of cardiology</article-title>. <source>Eur. J. heart Fail.</source> <volume>14</volume> (<issue>5</issue>), <fpage>451</fpage>&#x2013;<lpage>458</lpage>. <pub-id pub-id-type="doi">10.1093/eurjhf/hfs048</pub-id>
<pub-id pub-id-type="pmid">22499542</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coswig</surname>
<given-names>V. S.</given-names>
</name>
<name>
<surname>Barbalho</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Raiol</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Del Vecchio</surname>
<given-names>F. B.</given-names>
</name>
<name>
<surname>Ramirez-Campillo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gentil</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Effects of high vs moderate-intensity intermittent training on functionality, resting heart rate and blood pressure of elderly women</article-title>. <source>J. Transl. Med.</source> <volume>18</volume> (<issue>1</issue>), <fpage>88</fpage>. <pub-id pub-id-type="doi">10.1186/s12967-020-02261-8</pub-id>
<pub-id pub-id-type="pmid">32066460</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dawson</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Cable</surname>
<given-names>N. T.</given-names>
</name>
<name>
<surname>Thijssen</surname>
<given-names>D. H.</given-names>
</name>
</person-group> (<year>1985</year>). <article-title>Effects of acute exercise on flow-mediated dilatation in healthy humans</article-title>. <source>J. Appl. Physiol.</source> <volume>115</volume> (<issue>11</issue>), <fpage>1589</fpage>&#x2013;<lpage>1598</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00450.2013</pub-id>
<pub-id pub-id-type="pmid">24030665</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deka</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Pozehl</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Yates</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Adherence to recommended exercise guidelines in patients with heart failure</article-title>. <source>Heart Fail Rev.</source> <volume>22</volume> (<issue>1</issue>), <fpage>41</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1007/s10741-016-9584-1</pub-id>
<pub-id pub-id-type="pmid">27671166</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dub&#xe9;</surname>
<given-names>B.-P.</given-names>
</name>
<name>
<surname>Agostoni</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Laveneziana</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Exertional dyspnoea in chronic heart failure: the role of the lung and respiratory mechanical factors</article-title>. <source>Eur. Respir. Rev. Official J. Eur. Respir. Soc.</source> <volume>25</volume> (<issue>141</issue>), <fpage>317</fpage>&#x2013;<lpage>332</lpage>. <pub-id pub-id-type="doi">10.1183/16000617.0048-2016</pub-id>
<pub-id pub-id-type="pmid">27581831</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esposito</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Reese</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Shabetai</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>P. D.</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>R. S.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Isolated quadriceps training increases maximal exercise capacity in chronic heart failure: the role of skeletal muscle convective and diffusive oxygen transport</article-title>. <source>J. Am. Coll. Cardiol.</source> <volume>58</volume> (<issue>13</issue>), <fpage>1353</fpage>&#x2013;<lpage>1362</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2011.06.025</pub-id>
<pub-id pub-id-type="pmid">21920265</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gary</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Henning</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>McFarlin</surname>
<given-names>B. K.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Metabolic and cardiovascular responses on a novel, Whole body exercise Device compared to a cycle ergometer</article-title>. <source>Int. J. Exerc. Sci.</source> <volume>12</volume> (<issue>2</issue>), <fpage>1206</fpage>&#x2013;<lpage>1215</lpage>. <pub-id pub-id-type="doi">10.70252/KICB9258</pub-id>
<pub-id pub-id-type="pmid">31839844</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grace</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Gravely-Witte</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Brual</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Monette</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Suskin</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Higginson</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Contribution of patient and physician factors to cardiac rehabilitation enrollment: a prospective multilevel study</article-title>. <source>Eur. J. Cardiovasc. Prev. Rehabilitation Official J. Eur. Soc. Cardiol. Work. Groups Epidemiol. and Prev. Cardiac Rehabilitation Exerc. Physiology</source> <volume>15</volume> (<issue>5</issue>), <fpage>548</fpage>&#x2013;<lpage>556</lpage>. <pub-id pub-id-type="doi">10.1097/HJR.0b013e328305df05</pub-id>
<pub-id pub-id-type="pmid">18830085</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<collab>Health Qigong Management Center</collab> (<year>2003</year>). <article-title>Health Qigong management center of general administration of Sport of China: health Qigong-Baduanjin</article-title>.</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>MacDonald</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Morrison</surname>
<given-names>E. G.</given-names>
</name>
<name>
<surname>Shivgulam</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Pellerine</surname>
<given-names>L. P.</given-names>
</name>
<name>
<surname>Kimmerly</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Bray</surname>
<given-names>N. W.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Moderate intensity intermittent lifestyle physical activity is associated with better executive function in older adults</article-title>. <source>Front. Sports Act. Living</source> <volume>6</volume>, <fpage>1393214</fpage>. <pub-id pub-id-type="doi">10.3389/fspor.2024.1393214</pub-id>
<pub-id pub-id-type="pmid">38835704</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McDonagh</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Metra</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Adamo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gardner</surname>
<given-names>R. S.</given-names>
</name>
<name>
<surname>Baumbach</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>B&#xf6;hm</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure</article-title>. <source>Eur. Heart J.</source> <volume>44</volume> (<issue>37</issue>), <fpage>3627</fpage>&#x2013;<lpage>3639</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehad195</pub-id>
<pub-id pub-id-type="pmid">37622666</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miles</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Owens</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Golden</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Gotshall</surname>
<given-names>R. W.</given-names>
</name>
</person-group> (<year>1987</year>). <article-title>Central and peripheral hemodynamics during maximal leg extension exercise</article-title>. <source>Eur. J. Appl. Physiol. Occup. Physiol.</source> <volume>56</volume> (<issue>1</issue>), <fpage>12</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1007/bf00696369</pub-id>
<pub-id pub-id-type="pmid">3830135</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Molloy</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mordi</surname>
<given-names>I. R.</given-names>
</name>
<name>
<surname>Bridges</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sagar</surname>
<given-names>V. A.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>E. J.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Exercise-based cardiac rehabilitation for adults with heart failure</article-title>. <source>Cochrane Database Syst. Rev.</source> <volume>3</volume> (<issue>3</issue>), <fpage>CD003331</fpage>. <pub-id pub-id-type="doi">10.1002/14651858.CD003331.pub6</pub-id>
<pub-id pub-id-type="pmid">38451843</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Norton</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Norton</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sadgrove</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Position statement on physical activity and exercise intensity terminology</article-title>. <source>J. Sci. Med. sport</source> <volume>13</volume> (<issue>5</issue>), <fpage>496</fpage>&#x2013;<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsams.2009.09.008</pub-id>
<pub-id pub-id-type="pmid">20005170</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ozemek</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Squires</surname>
<given-names>R. W.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Enrollment and Adherence to early Outpatient and Maintenance cardiac rehabilitation programs</article-title>. <source>J. Cardiopulm. Rehabil. Prev.</source> <volume>41</volume> (<issue>6</issue>), <fpage>367</fpage>&#x2013;<lpage>374</lpage>. <pub-id pub-id-type="doi">10.1097/hcr.0000000000000645</pub-id>
<pub-id pub-id-type="pmid">34727555</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pelliccia</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gati</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>B&#xe4;ck</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>B&#xf6;rjesson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Caselli</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease</article-title>. <source>Eur. Heart J.</source> <volume>42</volume> (<issue>1</issue>), <fpage>17</fpage>&#x2013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehaa605</pub-id>
<pub-id pub-id-type="pmid">32860412</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ponikowski</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Voors</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Anker</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>Bueno</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cleland</surname>
<given-names>J. G. F.</given-names>
</name>
<name>
<surname>Coats</surname>
<given-names>A. J. S.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC</article-title>. <source>Eur. J. heart Fail.</source> <volume>18</volume> (<issue>8</issue>), <fpage>891</fpage>&#x2013;<lpage>975</lpage>. <pub-id pub-id-type="doi">10.1002/ejhf.592</pub-id>
<pub-id pub-id-type="pmid">27207191</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanderson</surname>
<given-names>B. K.</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Gerald</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>DiLillo</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Bittner</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Factors associated with the failure of patients to complete cardiac rehabilitation for medical and nonmedical reasons</article-title>. <source>J. Cardiopulm. Rehabilitation</source> <volume>23</volume> (<issue>4</issue>), <fpage>281</fpage>&#x2013;<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1097/00008483-200307000-00005</pub-id>
<pub-id pub-id-type="pmid">12894002</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>X. G.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Rehabilitation practice patterns for patients with heart failure: the Asian perspective</article-title>. <source>Heart Fail. Clin.</source> <volume>11</volume> (<issue>1</issue>), <fpage>95</fpage>&#x2013;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1016/j.hfc.2014.09.001</pub-id>
<pub-id pub-id-type="pmid">25432478</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Bonikowske</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Olson</surname>
<given-names>T. P.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Optimizing Outcomes in cardiac rehabilitation: the Importance of exercise intensity</article-title>. <source>Front. Cardiovasc. Med.</source> <volume>8</volume>, <fpage>734278</fpage>. <pub-id pub-id-type="doi">10.3389/fcvm.2021.734278</pub-id>
<pub-id pub-id-type="pmid">34540924</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wakeham</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Pierce</surname>
<given-names>G. L.</given-names>
</name>
<name>
<surname>Heffernan</surname>
<given-names>K. S.</given-names>
</name>
</person-group> (<year>2025a</year>). <article-title>Effect of acute resistance exercise and resistance exercise training on Central Pulsatile hemodynamics and Large artery stiffness: Part II</article-title>. <source>Pulse (Basel)</source> <volume>13</volume> (<issue>1</issue>), <fpage>45</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1159/000543314</pub-id>
<pub-id pub-id-type="pmid">39991442</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wakeham</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Pierce</surname>
<given-names>G. L.</given-names>
</name>
<name>
<surname>Heffernan</surname>
<given-names>K. S.</given-names>
</name>
</person-group> (<year>2025b</year>). <article-title>Effect of acute resistance exercise and resistance exercise training on Central Pulsatile hemodynamics and Large artery stiffness: Part I</article-title>. <source>Pulse (Basel)</source> <volume>13</volume> (<issue>1</issue>), <fpage>31</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1159/000543313</pub-id>
<pub-id pub-id-type="pmid">39991443</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X. Q.</given-names>
</name>
<name>
<surname>Pi</surname>
<given-names>Y. L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Traditional Chinese exercise for cardiovascular diseases: systematic review and meta-analysis of Randomized Controlled trials</article-title>. <source>J. Am. Heart Assoc.</source> <volume>5</volume> (<issue>3</issue>), <fpage>e002562</fpage>. <pub-id pub-id-type="doi">10.1161/jaha.115.002562</pub-id>
<pub-id pub-id-type="pmid">26961239</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The efficacy and physiological mechanisms of Baduanjin on dyspnea and exercise limitation in patients with COPD [in Chinese]</article-title>. <source>Massage Rehabilitation Med.</source> <volume>13</volume> (<issue>22</issue>), <fpage>46</fpage>&#x2013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.19787/j.issn.1008-1879.2022.22.012</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Pack</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Squires</surname>
<given-names>R. W.</given-names>
</name>
<name>
<surname>Lopez-Jimenez</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>R. J.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Availability and characteristics of cardiac rehabilitation programmes in China</article-title>. <source>Heart Asia</source> <volume>8</volume> (<issue>2</issue>), <fpage>9</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1136/heartasia-2016-010758</pub-id>
<pub-id pub-id-type="pmid">27326243</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Jianchao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D. W.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Availability and trend of dissemination of cardiac rehabilitation in China: report from the multicenter national registration platform between 2012 and 2021</article-title>. <source>Front. Cardiovasc Med.</source> <volume>10</volume>, <fpage>1210068</fpage>. <pub-id pub-id-type="doi">10.3389/fcvm.2023.1210068</pub-id>
<pub-id pub-id-type="pmid">37404729</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zou</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>SasaKi</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>A systematic review and meta-analysis Baduanjin Qigong for health benefits: Randomized Controlled trials</article-title>. <source>Evidence-based complementary Altern. Med. eCAM</source> <volume>2017</volume>, <fpage>4548706</fpage>. <pub-id pub-id-type="doi">10.1155/2017/4548706</pub-id>
<pub-id pub-id-type="pmid">28367223</pub-id>
</citation>
</ref>
</ref-list>
<sec id="s14">
<title>Glossary</title>
<def-list>
<def-item>
<term id="G1-fphys.2025.1620785">
<bold>CHF</bold>
</term>
<def>
<p>chronic heart failure</p>
</def>
</def-item>
<def-item>
<term id="G2-fphys.2025.1620785">
<bold>ICG</bold>
</term>
<def>
<p>impedance cardiography</p>
</def>
</def-item>
<def-item>
<term id="G3-fphys.2025.1620785">
<bold>CPET</bold>
</term>
<def>
<p>cardiopulmonary exercise testing</p>
</def>
</def-item>
<def-item>
<term id="G4-fphys.2025.1620785">
<bold>NYHA</bold>
</term>
<def>
<p>New York Heart Association</p>
</def>
</def-item>
<def-item>
<term id="G5-fphys.2025.1620785">
<bold>EqualVO</bold>
<sub>
<bold>2</bold>
</sub>
</term>
<def>
<p>the average oxygen consumption</p>
</def>
</def-item>
<def-item>
<term id="G6-fphys.2025.1620785">
<bold>VO</bold>
<sub>
<bold>2</bold>
</sub>
</term>
<def>
<p>volume of oxygen</p>
</def>
</def-item>
<def-item>
<term id="G7-fphys.2025.1620785">
<bold>V</bold>
<sub>
<bold>E</bold>
</sub>
</term>
<def>
<p>minute ventilation</p>
</def>
</def-item>
<def-item>
<term id="G8-fphys.2025.1620785">
<bold>CO</bold>
</term>
<def>
<p>cardiac output</p>
</def>
</def-item>
<def-item>
<term id="G9-fphys.2025.1620785">
<bold>EBCR</bold>
</term>
<def>
<p>exercise-based cardiac rehabilitation</p>
</def>
</def-item>
<def-item>
<term id="G10-fphys.2025.1620785">
<bold>HF</bold>
</term>
<def>
<p>heart failure</p>
</def>
</def-item>
<def-item>
<term id="G11-fphys.2025.1620785">
<bold>HR</bold>
</term>
<def>
<p>heart rate</p>
</def>
</def-item>
<def-item>
<term id="G12-fphys.2025.1620785">
<bold>SV</bold>
</term>
<def>
<p>stroke volume</p>
</def>
</def-item>
<def-item>
<term id="G13-fphys.2025.1620785">
<bold>CI</bold>
</term>
<def>
<p>contractility index</p>
</def>
</def-item>
<def-item>
<term id="G14-fphys.2025.1620785">
<bold>EDFR</bold>
</term>
<def>
<p>diastolic filling rate</p>
</def>
</def-item>
<def-item>
<term id="G15-fphys.2025.1620785">
<bold>SVR</bold>
</term>
<def>
<p>systemic vascular resistance</p>
</def>
</def-item>
<def-item>
<term id="G16-fphys.2025.1620785">
<bold>VO</bold>
<sub>
<bold>2</bold>
</sub>
<bold>max</bold>
</term>
<def>
<p>maximum oxygen consumption</p>
</def>
</def-item>
<def-item>
<term id="G17-fphys.2025.1620785">
<bold>RER</bold>
</term>
<def>
<p>respiratory exchange ratio</p>
</def>
</def-item>
<def-item>
<term id="G18-fphys.2025.1620785">
<bold>METs</bold>
</term>
<def>
<p>metabolic equivalents</p>
</def>
</def-item>
<def-item>
<term id="G19-fphys.2025.1620785">
<bold>HRmax</bold>
</term>
<def>
<p>maximum heart rate</p>
</def>
</def-item>
<def-item>
<term id="G20-fphys.2025.1620785">
<bold>O</bold>
<sub>
<bold>2</bold>
</sub>
<bold>pulse</bold>
</term>
<def>
<p>oxygen pulse</p>
</def>
</def-item>
<def-item>
<term id="G21-fphys.2025.1620785">
<bold>SBP</bold>
</term>
<def>
<p>systolic blood pressure</p>
</def>
</def-item>
<def-item>
<term id="G22-fphys.2025.1620785">
<bold>DBP</bold>
</term>
<def>
<p>diastolic blood pressure</p>
</def>
</def-item>
<def-item>
<term id="G23-fphys.2025.1620785">
<bold>HRR</bold>
<sub>
<bold>1</bold>
</sub>
</term>
<def>
<p>minute heart rate recovery</p>
</def>
</def-item>
<def-item>
<term id="G24-fphys.2025.1620785">
<bold>RR</bold>
</term>
<def>
<p>respiratory rate</p>
</def>
</def-item>
<def-item>
<term id="G25-fphys.2025.1620785">
<bold>P</bold>
<sub>
<bold>ET</bold>
</sub>
<bold>CO</bold>
<sub>
<bold>2</bold>
</sub>
</term>
<def>
<p>end-tidal carbon dioxide pressure</p>
</def>
</def-item>
<def-item>
<term id="G26-fphys.2025.1620785">
<bold>VE/VCO</bold>
<sub>
<bold>2</bold>
</sub>
</term>
<def>
<p>ventilation/carbon dioxide production</p>
</def>
</def-item>
<def-item>
<term id="G27-fphys.2025.1620785">
<bold>VE/VCO</bold>
<sub>
<bold>2</bold>
</sub> <bold>slope</bold>
</term>
<def>
<p>ventilation/carbon dioxide production slope</p>
</def>
</def-item>
<def-item>
<term id="G28-fphys.2025.1620785">
<bold>VT</bold>
</term>
<def>
<p>ventilatory threshold</p>
</def>
</def-item>
<def-item>
<term id="G29-fphys.2025.1620785">
<bold>AT</bold>
</term>
<def>
<p>anaerobic threshold</p>
</def>
</def-item>
<def-item>
<term id="G30-fphys.2025.1620785">
<bold>VCO</bold>
<sub>
<bold>2</bold>
</sub>
</term>
<def>
<p>volume of carbon dioxide</p>
</def>
</def-item>
<def-item>
<term id="G31-fphys.2025.1620785">
<bold>LVEF</bold>
</term>
<def>
<p>left ventricular ejection fraction</p>
</def>
</def-item>
<def-item>
<term id="G32-fphys.2025.1620785">
<bold>SD</bold>
</term>
<def>
<p>standard deviation</p>
</def>
</def-item>
<def-item>
<term id="G33-fphys.2025.1620785">
<bold>C(a-v)O</bold>
<sub>
<bold>2</bold>
</sub>
</term>
<def>
<p>elevated arterial-venous oxygen difference</p>
</def>
</def-item>
<def-item>
<term id="G34-fphys.2025.1620785">
<bold>BMI</bold>
</term>
<def>
<p>body mass index</p>
</def>
</def-item>
<def-item>
<term id="G35-fphys.2025.1620785">
<bold>bpm</bold>
</term>
<def>
<p>beats per minute</p>
</def>
</def-item>
<def-item>
<term id="G36-fphys.2025.1620785">
<bold>NT-proBNP</bold>
</term>
<def>
<p>N-terminal B-type natriuretic peptide</p>
</def>
</def-item>
<def-item>
<term id="G37-fphys.2025.1620785">
<bold>PASP</bold>
</term>
<def>
<p>pulmonary artery systolic pressure</p>
</def>
</def-item>
<def-item>
<term id="G38-fphys.2025.1620785">
<bold>MI</bold>
</term>
<def>
<p>myocardial infarction</p>
</def>
</def-item>
<def-item>
<term id="G39-fphys.2025.1620785">
<bold>MAX</bold>
</term>
<def>
<p>maximal intensity</p>
</def>
</def-item>
<def-item>
<term id="G40-fphys.2025.1620785">
<bold>O</bold>
<sub>
<bold>2</bold>
</sub> <bold>pulse</bold>
</term>
<def>
<p>oxygen pulse (oxygen consumption to heart rate ratio)</p>
</def>
</def-item>
<def-item>
<term id="G41-fphys.2025.1620785">
<bold>FEV</bold>
<sub>
<bold>1</bold>
</sub>
</term>
<def>
<p>forced expiratory volume in 1 s</p>
</def>
</def-item>
<def-item>
<term id="G42-fphys.2025.1620785">
<bold>FVC</bold>
</term>
<def>
<p>forced vital capacity</p>
</def>
</def-item>
<def-item>
<term id="G43-fphys.2025.1620785">
<bold>MVV</bold>
</term>
<def>
<p>maximum voluntary ventilation</p>
</def>
</def-item>
</def-list>
</sec>
</back>
</article>